SCHEMBL18847243

SCHEMBL18847243

c1ccc(-c2cc(-c3ccc(-c4cccc(-c5nc6ccccc6c6c5ccc5c7ccccc7oc56)c4)cc3)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 2/20 0.37
▸ PLA2G2A P14555 3/20 0.36
▸ PLA2G4A P47712 3/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ ACHE P22303 1/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ PDGFRB P09619 1/20 0.34
▸ KIT P10721 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ HDAC6 Q9UBN7 1/20 0.34
▸ PLA2G10 O15496 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ L3MBTL1 Q9Y468 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18847069 0.94 DHODH (0.39) DHODHALOX5ACHEMEN1MAPT
SCHEMBL18847115 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847493 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847445 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847242 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847245 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847124 0.93 MEN1 (0.37) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847123 0.93 MEN1 (0.36) DHODHPLA2G2APLA2G4AALOX5ACHE
SCHEMBL18847073 0.93 DHODH (0.41) DHODHMEN1MAPTKMT2ACSF1R
SCHEMBL18847288 0.92 ALDH1A1 (0.39) DHODHACHEMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446765-B2 Heterocyclic compound and organic light emitting element using same HEESUNG MATERIAL LTD. (KR) 2019-10-15 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME HEESUNG MATERIAL LTD. (KR) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170133602-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME CRY1, CRY2, PER2 DHODH 655/4885PLA2G2A 3967/4885PLA2G4A 3773/4885
US-10446765-B2 Heterocyclic compound and organic light emitting element using same CRY1, CRY2, PER2 DHODH 655/4885PLA2G2A 3967/4885PLA2G4A 3773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback